WEDNESDAY, Sept. 11, 2024 -- A proteomic signature indicating increased respiratory susceptibility identifies the risk for respiratory death, incident...

GSK announces positive data from a phase III study of Nucala (mepolizumab) in chronic obstructive pulmonary disease (COPD).

GSK announces positive data from a phase III study of Nucala (mepolizumab) in chronic obstructive pulmonary disease (COPD).

The post

The post

Insufficient green spaces and chronic exposure to air pollution can lead to more frequent hospital stays for respiratory illnesses. (!--ref1--)...

Highlights: Mirtazapine does not relieve breathlessness and may increase healthcare burden 19% of respiratory do

Discover the risks of off-label antidepressant prescriptions like mirtazapine for chronic respiratory disease.

Inquest into death finds euthanasia laws are ‘inadequate to provide for medication safety and to prevent deliberate misuse’

A new research review suggests that dentists could play a crucial role in detecting life-threatening sleep disorders like obstructive sleep apnea...